Catenae Innovation PLC (AIM: CTEA), the AIM-quoted provider of digital media and technology, announces that, further to the announcement made by the Company on 16 October 2020, it has renamed its 50/50 Joint Venture Company to Synovate Global Limited (“Synovate”) and Synovate has received its first orders.
Synovate is a joint venture between Catenae and BHA-Medical (“BHA”) in which Catenae licenses its technology platforms and BHA provides its Covid-19 CE-certified and scientifically validated by the UK Government Near-Patient Healgen Antigen test and its Covid-19 CE-certified Near-Patient Antai Triple-Antibody test.
Through Synovate, BHA has provided badminton’s national governing body – Badminton England with its Near-Patient Healgen Antigen test kits, and Catenae has supplied its GDPR-compliant data management platform, for the Badminton Europe Qualification Group 1 matches that took place in Milton Keynes between 9 – 12 December 2020.
Synovate’s partner, ECG Training, conducted the tests on the participating teams from England, Sweden, Estonia and Hungary, and all of the test results were securely logged and managed using Catenae’s platform through Synovate. The data was then submitted to Public Health England (PHE), for input into the NHS’s ‘Test and Trace’ platform, and the players received their test results via SMS text message and email.
Through Synovate, BHA’s Covid-19 test kits and Catenae’s data management platform have also been supplied to Stone Bailey, a security, safety and medical solutions organisation, for use at “Lapland UK”, a Christmas destination event near Ascot in Surrey.
Under the terms of the agreement with Stone Bailey, BHA provide the CE-certified Near-Patient Antai Triple-Antibody test kits for the venue staff, and have ensured that Stone Bailey received the training required to carry out the ongoing testing procedure. All test results are securely recorded on Catenae’s data management portal through Synovate and input into Public Health England.
Albeit neither the Badminton England nor the Stone Bailey agreements will generate significant revenues for the Company, it provides a commercial endorsement for Synovate’s offering.
The Synovate website can be viewed at this link: www.synovateglobal.com .
Guy Meyer, Chief Executive Officer of Catenae, said: “We are delighted to officially launch Synovate and to be able to provide commercial organisations with a comprehensive offering that they can use to test and securely manage Covid-19 cases within their corporations. Importantly, Synovate ensures that results from both Antigen and Antibody test are fed into PHE, where, in turn, they are inputted into the NHS’s ‘Test and Trace’ platform. Our platform is able to accept tests results from a range of differing testing procedures and is also able to accept an individual’s vaccination information.
“Utilising the sales expertise of our newly appointed Chief Commercial Officer, Nick Delacamp, we are experiencing increased interest for Synovate’s services from organisations across a range of industries, and we look forward to keeping the market updated on further progress in due course.”
Matt Stone, Managing Director of Stone Bailey, commented: “We are proud to be leading the way in managing the safety of our teams and visitors to Lapland UK. The testing system has made it quick and easy for us to conduct the tests and inform both the end-users and Public Health England of the outcomes.”
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Chief Executive Officer of the Company and the Directors of the Company accept responsibility for the content of this announcement.
About Catenae Innovation PLC
Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.
About Synovate Global
Synovate Global is a joint venture between BHA-Medical and Catenae Innovation PLC. BHA -Medical provides the most advanced technologies in the field of medicine. It combines this with clinical expertise and excellence to deliver an enriched quality of service for its customers across the globe.
Catenae is at the forefront of digital transformation globally. It provides a range of solutions which help organisations to better manage and control their operations through safe, secure Data Management Platforms, Digital Passport Apps and Dynamic Data Intelligence Dashboards.
Synovate Global’s purpose is to enable businesses and organisations to operate with confidence, safety and optimal efficiency. It helps to mitigate risk and proactively manage the population’s health status through cutting edge medical products, supported by clinical and occupational health services and underpinned by undisputed blockchain technology.
About Badminton England
Badminton England is the national governing body for the sport of badminton in England. It aims to govern, encourage and develop the sport throughout England.
About Stone Bailey
Stone Bailey is an organisation that provides a full security service and advise on safety, medical and risk management practices. Using its specialist knowledge and expertise in vigilance and diligence, it establishes a clear sense of direction to ensure it offers an exceptional service from concept to completion.
Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company’s current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as ‘anticipates,’ ‘expects,’ ‘intends,’ ‘plans,’ ‘believes,’ ‘seeks,’ ‘estimates,’ and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company’s control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.
The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned